News Coverage 11.06.19 Share on Twitter Share on Facebook Share on LinkedIn Early Results from First-In-U.S. Trial of CRISPR-Edited Immune Cells for Cancer Patients Suggest Safety of Approach Related Announcement CNBC Honors Dr. Karen Knudsen, PICI CEO, as Changemaker Research Update Data to Design: Inside Our Spring Scientific Retreat Announcement, Our Impact, Press Release PICI at ASCO: New Data. Big Impact. Top Honors.